AHIP's Jeanette Thornton explains where 2027 prior authorization standards fit in the affordability debate and what plans want from Congress.
News|Articles|July 10, 2025
Experts Highlight Consequences of Medicaid Rollbacks Due to Budget Bill
Author(s)Julia Bonavitacola
Fact checked by: Christina Mattina
A webinar held by KFF on July 9 emphasized the immediate effects of the new budget bill, highlighting the impacts on Medicaid and health spending in the next decade.
Advertisement
Advertisement
When the House passed the budget bill dubbed the One Big Beautiful Bill Act on July 3, 2025,1 health officials warned of the long-lasting effects that the move could have, including individuals losing health care coverage and the loss of funding for hospitals across the country.2 On July 9, KFF hosted a webinar to discuss some of these effects and explain how they would be addressed in the future.
Related to this article
In this Q&A, Rob Stransky of NiceRx explains how to screen patients for gray-market retatrutide use and why cost drives demand for unregulated peptides.
New CMS data let EBRI measure what employer plans owe after No Surprises Act arbitration: $8.39B in 2025, though premium impact is unclear.
In this part 2, Kirsten Axelsen, MS, discusses racial disparities, AI in prior authorization, and payers’ readiness for the next wave of CLL therapies.
Kirsten Axelsen, MS, discusses gaps in biomarker testing, nonmedical barriers, and utilization management from a new report on access to CLL care.
Proposals to drop race questions from the 2030 census and end EEOC workforce reporting could leave gaps in national racial data.
In 459 patients with FLT3-ITD AML given high-dose anthracycline induction, a high allelic ratio was not linked to survival.
From 9.6 million US diabetic retinopathy cases to a new FDA warning on GLP-1s, here are 5 things to know about diabetic eye disease this November.
Advertisement
Advertisement